Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on Stage 5 chronic kidney disease patients: A randomized crossover study

I. Wen Wu, Kuang Hung Hsu, Chio Yin Sun, Chi Jen Tsai, Mai-Szu Wu, Chin Chan Lee

研究成果: 雜誌貢獻文章同行評審

32 引文 斯高帕斯(Scopus)

摘要

Background. Indoxyl sulfate (IS) suppresses erythropoietin (EPO) activity and exerts renal damage. The oral adsorbent AST-120 reduces IS load and has antioxidant and renoprotective properties; however, its roles in the treatment of anemia remain unclear in chronic kidney disease (CKD) patients. Methods. Fifty-one Stage 5 predialysis CKD patients with hemoglobin
原文英語
頁(從 - 到)1719-1727
頁數9
期刊Nephrology Dialysis Transplantation
29
發行號9
DOIs
出版狀態已發佈 - 2014

ASJC Scopus subject areas

  • 腎臟病學
  • 移植
  • 醫藥 (全部)

指紋

深入研究「Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on Stage 5 chronic kidney disease patients: A randomized crossover study」主題。共同形成了獨特的指紋。

引用此